| |
| |
|
| Insider
Information: |
Hamelin Paul |
| Relationship: |
President |
| City: |
East Brunswick |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
124,765 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
124,765 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Savient Pharmaceuticals Inc |
SVNTQ |
President |
2011-02-14 |
124,765 |
2006-05-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
50 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2006-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
12,000 |
|
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2006-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
19,000 |
31,000 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2007-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
13,860 |
44,860 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2008-06-24 |
4 |
OE |
$5.11 |
$6,290 |
D/D |
1,231 |
39,650 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President |
• – – |
2009-05-26 |
4 |
AS |
$5.76 |
$6,791 |
D/D |
(1,179) |
95,855 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2007-10-15 |
4 |
OE |
$5.11 |
$8,518 |
D/D |
1,667 |
45,307 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President |
• – – |
2009-02-17 |
4/A |
AS |
$5.77 |
$10,252 |
D/D |
(1,777) |
97,034 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President |
• – – |
2009-12-17 |
4 |
AS |
$5.77 |
$10,252 |
D/D |
(1,777) |
97,034 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President |
• – – |
2008-12-09 |
4 |
AS |
$4.71 |
$11,853 |
D/D |
(2,515) |
48,811 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2007-10-03 |
4 |
OE |
$5.11 |
$12,775 |
D/D |
2,500 |
46,140 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2007-10-05 |
4 |
OE |
$5.11 |
$12,775 |
D/D |
2,500 |
46,140 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP - Commerical Operations |
• – – |
2008-11-04 |
4 |
D |
$5.17 |
$15,127 |
D/D |
(2,926) |
44,993 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2007-12-14 |
4 |
OE |
$5.11 |
$17,032 |
D/D |
3,333 |
44,620 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2007-05-23 |
4 |
AS |
$14.35 |
$17,506 |
D/D |
(1,220) |
43,640 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2008-06-19 |
4/A |
OE |
$12.11 |
$23,348 |
D/D |
1,928 |
40,347 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2008-06-19 |
4 |
OE |
$12.11 |
$23,348 |
D/D |
1,928 |
41,579 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2007-12-13 |
4 |
OE |
$5.11 |
$25,550 |
D/D |
5,000 |
46,287 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2008-06-23 |
4/A |
OE |
$5.11 |
$25,550 |
D/D |
5,000 |
43,419 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2007-10-15 |
4 |
S |
$15.52 |
$25,872 |
D/D |
(1,667) |
43,640 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President |
• – – |
2009-12-09 |
4 |
AS |
$13.36 |
$26,476 |
D/D |
(1,981) |
89,874 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
President |
• – – |
2008-12-08 |
4 |
A |
$4.53 |
$28,688 |
D/D |
6,333 |
51,326 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2008-01-02 |
4 |
OE |
$12.11 |
$28,761 |
D/D |
2,375 |
43,662 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2008-02-01 |
4 |
OE |
$12.11 |
$28,761 |
D/D |
2,375 |
43,662 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2008-03-03 |
4 |
OE |
$12.11 |
$28,761 |
D/D |
2,375 |
42,026 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Commercial Operations |
• – – |
2008-05-23 |
4 |
AS |
$24.09 |
$29,679 |
D/D |
(1,232) |
38,419 |
0 |
- |
|
50 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
